Concepts (316)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondrial Diseases | 17 | 2023 | 342 | 5.440 |
Why?
|
| Mitochondrial Myopathies | 5 | 2024 | 50 | 3.230 |
Why?
|
| Oligopeptides | 3 | 2024 | 1179 | 1.510 |
Why?
|
| Fabry Disease | 5 | 2024 | 87 | 0.960 |
Why?
|
| Endothelin-1 | 11 | 2016 | 302 | 0.730 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 1 | 2019 | 50 | 0.640 |
Why?
|
| Oxidative Stress | 4 | 2016 | 3114 | 0.620 |
Why?
|
| Keratoacanthoma | 2 | 2008 | 33 | 0.600 |
Why?
|
| Information Services | 1 | 2019 | 236 | 0.590 |
Why?
|
| DNA, Mitochondrial | 6 | 2024 | 865 | 0.550 |
Why?
|
| Fatigue | 2 | 2023 | 1550 | 0.530 |
Why?
|
| MELAS Syndrome | 4 | 2024 | 56 | 0.530 |
Why?
|
| Neuromuscular Agents | 1 | 2018 | 148 | 0.530 |
Why?
|
| Rare Diseases | 1 | 2019 | 624 | 0.440 |
Why?
|
| Nitric Oxide Synthase Type III | 6 | 2016 | 705 | 0.440 |
Why?
|
| Lipopolysaccharides | 7 | 2016 | 2199 | 0.410 |
Why?
|
| Quality of Life | 3 | 2023 | 13367 | 0.400 |
Why?
|
| Vision Disorders | 1 | 2019 | 1089 | 0.390 |
Why?
|
| Genotype | 3 | 2024 | 12985 | 0.370 |
Why?
|
| Heart Diseases | 2 | 2022 | 2795 | 0.370 |
Why?
|
| Leigh Disease | 2 | 2023 | 89 | 0.370 |
Why?
|
| Liver | 8 | 2006 | 7512 | 0.360 |
Why?
|
| Ethanol | 2 | 2008 | 1322 | 0.360 |
Why?
|
| Nitric Oxide Synthase | 4 | 2005 | 909 | 0.350 |
Why?
|
| Heart Ventricles | 1 | 2022 | 3813 | 0.340 |
Why?
|
| Enzyme Replacement Therapy | 4 | 2024 | 80 | 0.340 |
Why?
|
| Kupffer Cells | 2 | 2006 | 143 | 0.320 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2008 | 64 | 0.310 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 2923 | 0.290 |
Why?
|
| alpha-Galactosidase | 2 | 2024 | 57 | 0.280 |
Why?
|
| S-Adenosylmethionine | 1 | 2008 | 218 | 0.280 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2007 | 96 | 0.280 |
Why?
|
| Endotoxins | 2 | 2006 | 520 | 0.270 |
Why?
|
| Nervous System Diseases | 1 | 2017 | 1663 | 0.270 |
Why?
|
| Health Care Costs | 1 | 2018 | 3239 | 0.250 |
Why?
|
| Eicosanoids | 1 | 2006 | 282 | 0.240 |
Why?
|
| Pregnancy Complications | 1 | 2018 | 2949 | 0.230 |
Why?
|
| Ubiquinone | 2 | 2016 | 183 | 0.230 |
Why?
|
| Merozoite Surface Protein 1 | 1 | 2023 | 37 | 0.220 |
Why?
|
| Double-Blind Method | 4 | 2023 | 12341 | 0.210 |
Why?
|
| Muscle Fatigue | 1 | 2023 | 95 | 0.210 |
Why?
|
| Nonmuscle Myosin Type IIB | 1 | 2022 | 21 | 0.210 |
Why?
|
| Diagnosis, Differential | 8 | 2020 | 12976 | 0.200 |
Why?
|
| Endothelial Cells | 4 | 2016 | 3552 | 0.200 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 2 | 2013 | 134 | 0.190 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2006 | 1168 | 0.190 |
Why?
|
| Acidosis, Lactic | 2 | 2020 | 146 | 0.190 |
Why?
|
| Mucopolysaccharidoses | 1 | 2021 | 27 | 0.190 |
Why?
|
| Hepatocytes | 1 | 2008 | 1230 | 0.190 |
Why?
|
| Mitochondria | 4 | 2023 | 3620 | 0.180 |
Why?
|
| Humans | 49 | 2024 | 761222 | 0.180 |
Why?
|
| Ceruloplasmin | 1 | 2020 | 56 | 0.180 |
Why?
|
| Iron Metabolism Disorders | 1 | 2020 | 24 | 0.180 |
Why?
|
| RNA, Transfer, Leu | 2 | 2024 | 13 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2008 | 8164 | 0.170 |
Why?
|
| Triterpenes | 1 | 2020 | 76 | 0.170 |
Why?
|
| Isoenzymes | 1 | 2024 | 1682 | 0.170 |
Why?
|
| Societies, Scientific | 1 | 2020 | 223 | 0.160 |
Why?
|
| Color Vision Defects | 1 | 2019 | 28 | 0.160 |
Why?
|
| Rhabdomyolysis | 1 | 2020 | 152 | 0.160 |
Why?
|
| Muscle Strength | 1 | 2023 | 624 | 0.160 |
Why?
|
| Ophthalmoplegia, Chronic Progressive External | 1 | 2018 | 17 | 0.160 |
Why?
|
| Male | 32 | 2024 | 360703 | 0.160 |
Why?
|
| Skin Neoplasms | 2 | 2008 | 5809 | 0.150 |
Why?
|
| Scotoma | 1 | 2019 | 128 | 0.150 |
Why?
|
| Homocystinuria | 1 | 2018 | 64 | 0.150 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2018 | 110 | 0.140 |
Why?
|
| Endothelium, Vascular | 2 | 2005 | 4420 | 0.130 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 5842 | 0.130 |
Why?
|
| Orbit | 1 | 2019 | 457 | 0.130 |
Why?
|
| Female | 22 | 2024 | 392552 | 0.130 |
Why?
|
| Optic Nerve | 1 | 2019 | 571 | 0.130 |
Why?
|
| Glomerular Filtration Rate | 1 | 2024 | 2182 | 0.130 |
Why?
|
| Stroke | 2 | 2017 | 9721 | 0.130 |
Why?
|
| Genetic Counseling | 1 | 2019 | 628 | 0.120 |
Why?
|
| Endothelins | 2 | 2006 | 127 | 0.120 |
Why?
|
| Superoxides | 1 | 2016 | 388 | 0.120 |
Why?
|
| Rats | 11 | 2008 | 23705 | 0.120 |
Why?
|
| Gastrointestinal Diseases | 1 | 2023 | 1201 | 0.120 |
Why?
|
| Carnitine | 1 | 2016 | 252 | 0.120 |
Why?
|
| Kearns-Sayre Syndrome | 1 | 2014 | 6 | 0.120 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2014 | 27 | 0.120 |
Why?
|
| Adult | 15 | 2024 | 221120 | 0.120 |
Why?
|
| Caveolins | 2 | 2005 | 102 | 0.120 |
Why?
|
| Homocysteine | 1 | 2018 | 637 | 0.120 |
Why?
|
| Recombinant Proteins | 1 | 2024 | 6504 | 0.120 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2006 | 517 | 0.110 |
Why?
|
| Guidelines as Topic | 1 | 2020 | 1385 | 0.110 |
Why?
|
| Diabetes Insipidus | 1 | 2014 | 144 | 0.110 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 2082 | 0.110 |
Why?
|
| Standard of Care | 1 | 2017 | 550 | 0.110 |
Why?
|
| Dietary Supplements | 2 | 2016 | 3410 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2020 | 10756 | 0.110 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2018 | 556 | 0.110 |
Why?
|
| Middle Aged | 12 | 2024 | 220858 | 0.110 |
Why?
|
| Lymphocyte Activation | 1 | 2024 | 5478 | 0.110 |
Why?
|
| Hydrogen Peroxide | 2 | 2006 | 731 | 0.100 |
Why?
|
| Ataxia | 1 | 2014 | 305 | 0.100 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2017 | 781 | 0.100 |
Why?
|
| Phosphorylation | 4 | 2006 | 8300 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1086 | 0.100 |
Why?
|
| Muscle Weakness | 1 | 2014 | 412 | 0.090 |
Why?
|
| Neurodegenerative Diseases | 1 | 2020 | 1085 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2006 | 4567 | 0.090 |
Why?
|
| Liver Circulation | 3 | 2005 | 159 | 0.090 |
Why?
|
| Medicine | 1 | 2019 | 942 | 0.090 |
Why?
|
| Adolescent | 7 | 2024 | 88300 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 1812 | 0.090 |
Why?
|
| Polymorphism, Genetic | 1 | 2020 | 4243 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2008 | 18222 | 0.080 |
Why?
|
| Patients | 1 | 2016 | 906 | 0.080 |
Why?
|
| Blotting, Western | 3 | 2005 | 5032 | 0.080 |
Why?
|
| Visual Acuity | 1 | 2019 | 2676 | 0.080 |
Why?
|
| Potassium Channels | 1 | 2012 | 537 | 0.080 |
Why?
|
| Emotions | 1 | 2021 | 2742 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 2731 | 0.080 |
Why?
|
| Treatment Outcome | 6 | 2024 | 64681 | 0.080 |
Why?
|
| Skin Diseases, Vesiculobullous | 1 | 2010 | 85 | 0.080 |
Why?
|
| Disease Management | 2 | 2017 | 2507 | 0.080 |
Why?
|
| Cheek | 1 | 2008 | 65 | 0.080 |
Why?
|
| Mutation | 4 | 2020 | 30004 | 0.080 |
Why?
|
| Immunity | 1 | 2014 | 996 | 0.080 |
Why?
|
| Brain | 4 | 2020 | 27094 | 0.080 |
Why?
|
| Retina | 1 | 2019 | 2656 | 0.080 |
Why?
|
| Nutritional Status | 1 | 2016 | 1597 | 0.080 |
Why?
|
| Vitamins | 1 | 2016 | 1634 | 0.070 |
Why?
|
| Seizures | 2 | 2018 | 2965 | 0.070 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2018 | 1462 | 0.070 |
Why?
|
| Data Collection | 1 | 2017 | 3320 | 0.070 |
Why?
|
| Pemphigus | 1 | 2008 | 107 | 0.070 |
Why?
|
| Young Adult | 5 | 2024 | 59222 | 0.070 |
Why?
|
| Liver Diseases | 1 | 2016 | 1301 | 0.070 |
Why?
|
| RNA | 3 | 2005 | 2709 | 0.070 |
Why?
|
| Caveolin 1 | 2 | 2006 | 255 | 0.070 |
Why?
|
| Liver Function Tests | 1 | 2008 | 525 | 0.070 |
Why?
|
| Sulfonamides | 2 | 2006 | 1977 | 0.070 |
Why?
|
| Immunoglobulin A | 1 | 2010 | 979 | 0.070 |
Why?
|
| Alanine Transaminase | 2 | 2006 | 602 | 0.070 |
Why?
|
| Liver Cirrhosis, Experimental | 1 | 2006 | 29 | 0.060 |
Why?
|
| Immunoprecipitation | 2 | 2005 | 874 | 0.060 |
Why?
|
| United States | 3 | 2019 | 72341 | 0.060 |
Why?
|
| Oxidants | 1 | 2006 | 169 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2020 | 3417 | 0.060 |
Why?
|
| Phospholipases A | 1 | 2006 | 204 | 0.060 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 2024 | 0.060 |
Why?
|
| Receptor, Endothelin B | 1 | 2005 | 45 | 0.060 |
Why?
|
| Microcirculation | 3 | 2005 | 1280 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2020 | 6567 | 0.060 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2006 | 123 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2016 | 2092 | 0.060 |
Why?
|
| Free Radicals | 1 | 2005 | 238 | 0.060 |
Why?
|
| Thromboxane A2 | 1 | 2005 | 88 | 0.060 |
Why?
|
| Threonine | 1 | 2005 | 270 | 0.060 |
Why?
|
| Anxiety | 1 | 2019 | 4569 | 0.060 |
Why?
|
| Child | 6 | 2023 | 80154 | 0.060 |
Why?
|
| Hepatitis | 1 | 2005 | 228 | 0.060 |
Why?
|
| Multiple Sclerosis | 1 | 2018 | 3222 | 0.050 |
Why?
|
| Endotoxemia | 1 | 2005 | 196 | 0.050 |
Why?
|
| Child, Preschool | 5 | 2018 | 42225 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 10203 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2006 | 3577 | 0.050 |
Why?
|
| Graft Rejection | 1 | 2016 | 4481 | 0.050 |
Why?
|
| Nitric Oxide | 2 | 2016 | 2137 | 0.050 |
Why?
|
| Infant | 4 | 2018 | 36170 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 17897 | 0.050 |
Why?
|
| Parents | 1 | 2016 | 3564 | 0.050 |
Why?
|
| Ultraviolet Rays | 1 | 2007 | 1078 | 0.050 |
Why?
|
| Penetrance | 1 | 2023 | 382 | 0.050 |
Why?
|
| Phenotype | 4 | 2023 | 16575 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15841 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2005 | 1756 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2017 | 3434 | 0.050 |
Why?
|
| Necrosis | 1 | 2005 | 1610 | 0.050 |
Why?
|
| Fibrosis | 1 | 2008 | 2052 | 0.050 |
Why?
|
| Research Design | 1 | 2017 | 6180 | 0.050 |
Why?
|
| Syndrome | 1 | 2007 | 3271 | 0.050 |
Why?
|
| Pain | 1 | 2016 | 5072 | 0.050 |
Why?
|
| Animals | 13 | 2012 | 168089 | 0.050 |
Why?
|
| Myosin Heavy Chains | 1 | 2022 | 403 | 0.050 |
Why?
|
| Chelation Therapy | 1 | 2020 | 77 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2018 | 80675 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 4851 | 0.040 |
Why?
|
| Genome, Mitochondrial | 1 | 2020 | 67 | 0.040 |
Why?
|
| Depression | 1 | 2019 | 8132 | 0.040 |
Why?
|
| Toxicity Tests | 1 | 2020 | 114 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2020 | 36415 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2008 | 1885 | 0.040 |
Why?
|
| Constipation | 1 | 2023 | 564 | 0.040 |
Why?
|
| Decision Trees | 1 | 2020 | 505 | 0.040 |
Why?
|
| Unconsciousness | 1 | 2020 | 249 | 0.040 |
Why?
|
| RNA, Messenger | 4 | 2006 | 12747 | 0.040 |
Why?
|
| Cell Survival | 2 | 2005 | 5778 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2006 | 1967 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2018 | 26200 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2005 | 2916 | 0.040 |
Why?
|
| Cilia | 1 | 2022 | 495 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2008 | 2981 | 0.040 |
Why?
|
| Ferritins | 1 | 2020 | 596 | 0.040 |
Why?
|
| Hedgehog Proteins | 1 | 2022 | 769 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 2010 | 2244 | 0.040 |
Why?
|
| Aged | 2 | 2022 | 169292 | 0.040 |
Why?
|
| Siblings | 1 | 2021 | 824 | 0.040 |
Why?
|
| Genes, Mitochondrial | 1 | 2017 | 58 | 0.040 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2020 | 371 | 0.030 |
Why?
|
| Blood Flow Velocity | 3 | 2005 | 1375 | 0.030 |
Why?
|
| Reference Standards | 1 | 2020 | 1005 | 0.030 |
Why?
|
| Biopsy | 1 | 2008 | 6781 | 0.030 |
Why?
|
| Pregnancy | 1 | 2018 | 29893 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2006 | 2047 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2022 | 1067 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2020 | 848 | 0.030 |
Why?
|
| Marfan Syndrome | 1 | 2018 | 236 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2006 | 4909 | 0.030 |
Why?
|
| Actins | 1 | 2022 | 2046 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 54437 | 0.030 |
Why?
|
| Body Weight | 1 | 2005 | 4618 | 0.030 |
Why?
|
| Drug Design | 1 | 2020 | 1044 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2020 | 1139 | 0.030 |
Why?
|
| Microscopy, Video | 2 | 2005 | 241 | 0.030 |
Why?
|
| Haplotypes | 1 | 2020 | 2715 | 0.030 |
Why?
|
| Internationality | 1 | 2020 | 999 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 2006 | 2527 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2006 | 18927 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2020 | 1741 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2016 | 593 | 0.030 |
Why?
|
| Brain Edema | 1 | 2018 | 604 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 1838 | 0.030 |
Why?
|
| Lymphocyte Subsets | 1 | 2014 | 312 | 0.030 |
Why?
|
| Ganglia, Spinal | 1 | 2016 | 525 | 0.030 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2016 | 370 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2005 | 4027 | 0.030 |
Why?
|
| Models, Biological | 2 | 2006 | 9458 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 1838 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 11067 | 0.020 |
Why?
|
| Exercise Test | 1 | 2020 | 2165 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2024 | 4373 | 0.020 |
Why?
|
| Tunisia | 1 | 2010 | 36 | 0.020 |
Why?
|
| Perfusion | 2 | 2005 | 1390 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2010 | 66 | 0.020 |
Why?
|
| Consensus | 1 | 2020 | 3134 | 0.020 |
Why?
|
| Dapsone | 1 | 2010 | 56 | 0.020 |
Why?
|
| Erythromycin | 1 | 2010 | 114 | 0.020 |
Why?
|
| Hospitals | 1 | 2023 | 3881 | 0.020 |
Why?
|
| Time Factors | 3 | 2005 | 39957 | 0.020 |
Why?
|
| Caregivers | 1 | 2021 | 2244 | 0.020 |
Why?
|
| Internet | 1 | 2021 | 3096 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 2138 | 0.020 |
Why?
|
| Heart Rate | 1 | 2020 | 4197 | 0.020 |
Why?
|
| Complement Activation | 1 | 2010 | 445 | 0.020 |
Why?
|
| Prednisolone | 1 | 2008 | 324 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2012 | 839 | 0.020 |
Why?
|
| Registries | 1 | 2022 | 8246 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2270 | 0.020 |
Why?
|
| Erythrocytes | 2 | 2005 | 2413 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2012 | 1318 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2019 | 3537 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2016 | 3549 | 0.020 |
Why?
|
| Thromboxane-A Synthase | 1 | 2005 | 34 | 0.020 |
Why?
|
| Receptors, Thromboxane | 1 | 2005 | 30 | 0.020 |
Why?
|
| Portal System | 1 | 2005 | 49 | 0.020 |
Why?
|
| Prednisone | 1 | 2010 | 1565 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 20118 | 0.020 |
Why?
|
| Portal Pressure | 1 | 2005 | 60 | 0.020 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2005 | 222 | 0.020 |
Why?
|
| Pedigree | 1 | 2012 | 4537 | 0.010 |
Why?
|
| Migraine Disorders | 1 | 2017 | 1701 | 0.010 |
Why?
|
| Life Style | 1 | 2016 | 3907 | 0.010 |
Why?
|
| Benzofurans | 1 | 2005 | 139 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 2016 | 2332 | 0.010 |
Why?
|
| Comorbidity | 1 | 2018 | 10516 | 0.010 |
Why?
|
| Remission Induction | 1 | 2010 | 2392 | 0.010 |
Why?
|
| Fractures, Closed | 1 | 2004 | 88 | 0.010 |
Why?
|
| Calmodulin | 1 | 2004 | 217 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2006 | 597 | 0.010 |
Why?
|
| Hydrazines | 1 | 2005 | 222 | 0.010 |
Why?
|
| Exercise | 1 | 2020 | 5874 | 0.010 |
Why?
|
| Automation | 1 | 2005 | 585 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2012 | 4243 | 0.010 |
Why?
|
| Catalysis | 1 | 2004 | 763 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 4537 | 0.010 |
Why?
|
| Fracture Healing | 1 | 2005 | 445 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 7400 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 2005 | 592 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2016 | 3258 | 0.010 |
Why?
|
| Cell Line | 1 | 2016 | 15545 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2005 | 23419 | 0.010 |
Why?
|
| Feedback | 1 | 2006 | 790 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 4947 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12728 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2005 | 540 | 0.010 |
Why?
|
| DNA Primers | 1 | 2006 | 2814 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 22128 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 2016 | 4242 | 0.010 |
Why?
|
| Gadolinium | 1 | 2005 | 961 | 0.010 |
Why?
|
| Protein Transport | 1 | 2005 | 1958 | 0.010 |
Why?
|
| Femur | 1 | 2005 | 1308 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 20982 | 0.010 |
Why?
|
| Cell Division | 1 | 2006 | 4451 | 0.010 |
Why?
|
| Kinetics | 1 | 2005 | 6312 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 6200 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 2635 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 1901 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2006 | 2019 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2005 | 3661 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 20588 | 0.010 |
Why?
|
| Wound Healing | 1 | 2005 | 2800 | 0.010 |
Why?
|
| Skin | 1 | 2006 | 4473 | 0.010 |
Why?
|
| Mice | 2 | 2012 | 81330 | 0.010 |
Why?
|
| Peptides | 1 | 2004 | 4353 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 9297 | 0.010 |
Why?
|
| Age Factors | 1 | 2008 | 18384 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 2004 | 2493 | 0.010 |
Why?
|
| Sepsis | 1 | 2005 | 2585 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 74241 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2005 | 8998 | 0.000 |
Why?
|
| Inflammation | 1 | 2005 | 10759 | 0.000 |
Why?
|
Concepts
(316)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(42)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_